NATIONAL HARBOR, MD. – Prophylactic use of probiotics appeared to reduce the odds of developing antibiotic-associated diarrhea by 60%, based on data from a meta-analysis of more than 3,000 patients. The findings were presented at the annual meeting of the American College of Gastroenterology.
The incidence and severity of antibiotic-associated diarrhea (AAD) are increasing in the United States, with major financial and clinical implications, said Dr. Steven Shamah, a resident in Internal Medicine at Maimonides Medical Center in Brooklyn, N.Y.
"Given the enormous cost, morbidity, and mortality associated with this [disorder], it is important to identify those at-risk populations and institute preventative measures," Dr. Shamah said. The most common type of AAD is Clostridium difficile–associated diarrhea (CDAD), he said.
More...
Abstract
OBJECTIVE:
Probiotics are increasingly advocated in the management of various gastrointestinal disorders. The aim of this study was to investigate the current attitudes and prescribing practices of surgeons and gastroenterologists for probiotics in the treatment of gastrointestinal disorders.
METHODS:
A questionnaire was designed to look at the frequency of probiotic prescribing, types of probiotics used, indications for and duration of treatment and clinicians' experiences with probiotic use. A total of 220 questionnaires were mailed to consultant gastroenterologists and surgeons practicing in the UK.
RESULTS:
The overall response rate was 80.5%, of which 69.5% of respondents said they recommended or prescribed probiotic food supplements to their patients, including 53.4% of surgeons and 80.8% of gastroenterologists (P = 0.00013). The most popular probiotic supplements among surgeons were probiotic-containing yoghurt and drinks (79.5% and 71.8%, respectively), whereas VSL#3 was more popular with gastroenterologists (83.3%). The most popular indications were irritable bowel syndrome (70.7% of prescribers) and pouchitis (67.5% of prescribers). Many respondents prescribed long-term probiotics. Most consultants had been prescribing probiotics for a period of 1 to 5 years.
More...
SICHUAN, China, Dec. 2 (UPI) -- Probiotics, added to nutrients supplied through a feeding tube to a patient with a traumatic brain injury, may improve outcomes, Chinese researchers suggest.
Professor Jing-Ci Zhu -- study leader from the Third Military Medical University School of Nursing and colleagues at the North Sichuan Medical College and Hospital in China -- said traumatic brain injury is associated with a profound suppression of a patient's ability to fight infection. Probiotics, found in yogurt and supplements, are live microorganisms thought to be beneficial to the host organism.
Patients often suffer hyper-inflammation due to the brain releasing glucocorticoids in response to the injury, the researchers said.
More...
For decades, if not centuries, a variety of products with what would now be regarded as prebiotic and probiotic properties have been consumed by the general public and advocated for their benefits on health and, in particular, gastrointestinal well-being. More recently, medical science has taken a great interest in the population of micro-organisms, the gut microbiota that normally populates the human gut, and the range of important functions carried out by the microbiota in health is being progressively defined. As a corollary, the list of disorders and diseases that may result from disruption of the normal microbiota and/or its interaction with the host continues to grow. A scientific basis for the use of probiotics and prebiotics is, therefore, beginning to emerge. Unfortunately, although progress has been made, the clinical evidence to support the use of these preparations lags behind. Nevertheless, a number of human disease states may benefit from the use of probiotics, most notably, diarrheal illnesses, some inflammatory bowel diseases, certain infectious disorders, and irritable bowel syndrome. Prebiotics promote the growth of "good" bacteria, and although a variety of health benefits have been attributed to their use, prebiotics have been subjected to few large-scale clinical trials. (Nutr Clin Pract. XXXX;XX:xx-xx).
Abstract
OBJECTIVE:
Oxidative stress plays a major role in the pathogenesis and progression of diabetes. Among various functional foods with an antioxidant effect, probiotic foods have been reported to repress oxidative stress. The objective of this clinical trial was to assess the effects of probiotic and conventional yogurt on blood glucose and antioxidant status in type 2 diabetic patients.
METHODS:
Sixty-four patients with type 2 diabetes mellitus, 30 to 60 y old, were assigned to two groups in this randomized, double-blind, controlled clinical trial. The patients in the intervention group consumed 300 g/d of probiotic yogurt containing Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 and those in the control group consumed 300 g/d of conventional yogurt for 6 wk. Fasting blood samples, 24-h dietary recalls, and anthropometric measurements were collected at the baseline and at the end of the trial.
RESULTS:
Probiotic yogurt significantly decreased fasting blood glucose (P < 0.01) and hemoglobin A1c (P < 0.05) and increased erythrocyte superoxide dismutase and glutathione peroxidase activities and total antioxidant status (P < 0.05) compared with the control group. In addition, the serum malondialdehyde concentration significantly decreased compared with the baseline value in both groups (P < 0.05). No significant changes from baseline were shown in insulin concentration and erythrocyte catalase activity within either group (P > 0.05).
More...
Comments
Post has no comments.